Ethics of controlled human infection to address COVID-19
Open Access
- 22 May 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 368 (6493) , 832-834
Abstract
High social value is fundamental to justifying these studiesKeywords
This publication has 12 references indexed in Scilit:
- Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidatesVaccine, 2019
- Experimental infection of human volunteersThe Lancet Infectious Diseases, 2018
- Bystander risk, social value, and ethics of human researchScience, 2018
- Ethical Criteria for Human Challenge Studies in Infectious Diseases: Table 1.Public Health Ethics, 2015
- Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trialsBMC Medical Ethics, 2013
- Limits on risks for healthy volunteers in biomedical researchTheoretical Medicine and Bioethics, 2011
- A Framework for Risk-Benefit Evaluations in Biomedical ResearchKennedy Institute of Ethics Journal, 2011
- More than the money: A review of the literature examining healthy volunteer motivationsContemporary Clinical Trials, 2011
- Limits to research risksJournal of Medical Ethics, 2009